Cargando…

Embedding assessment of liver fibrosis into routine diabetic review in primary care

BACKGROUND & AIMS: Individuals with type 2 diabetes (T2DM) are at high risk of developing non-alcoholic fatty liver disease (NAFLD) and advanced fibrosis/cirrhosis. Screening patients with T2DM and normal liver enzymes for NAFLD in primary care remains contentious. Our aim was to develop and ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansour, Dina, Grapes, Allison, Herscovitz, Marc, Cassidy, Paul, Vernazza, Jonathan, Broad, Andrea, Anstee, Quentin M., McPherson, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213901/ https://www.ncbi.nlm.nih.gov/pubmed/34179738 http://dx.doi.org/10.1016/j.jhepr.2021.100293

Ejemplares similares

Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
por: Dyson, Jessica K, et al.
Publicado: (2014)

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
por: Hardy, Timothy, et al.
Publicado: (2017)

Nutrigenetics-based intervention approach for adults with non-alcoholic fatty liver disease (NAFLD): study protocol for a randomised controlled feasibility trial
por: Haigh, Laura, et al.
Publicado: (2021)

Factors associated with engagement and adherence to a low-energy diet to promote 10% weight loss in patients with clinically significant non-alcoholic fatty liver disease
por: Scragg, Jadine, et al.
Publicado: (2021)

Stratification Of LIver Disease (SOLID): protocol for a prospective observational cohort study to determine the optimum biomarker strategies for the detection of advanced liver disease at the primary–secondary care interface
por: McPherson, Stuart, et al.
Publicado: (2023)

Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study
por: Hallsworth, Kate, et al.
Publicado: (2019)

Feasibility of a Very Low Calorie Diet to Achieve a Sustainable 10% Weight Loss in Patients With Nonalcoholic Fatty Liver Disease
por: Scragg, Jadine, et al.
Publicado: (2020)

Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping
por: Hallsworth, Kate, et al.
Publicado: (2021)

Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial
por: Houghton, David, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease: a practical approach to treatment
por: Dyson, J K, et al.
Publicado: (2014)

Republished: Non-alcoholic fatty liver disease: a practical approach to treatment
por: Dyson, J K, et al.
Publicado: (2015)

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
por: McPherson, Stuart, et al.
Publicado: (2017)

Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease
por: Karsdal, Morten A., et al.
Publicado: (2023)

TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
por: Liu, Yang-Lin, et al.
Publicado: (2014)

Thrombin and factor Xa link the coagulation system with liver fibrosis
por: Dhar, Ameet, et al.
Publicado: (2018)

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease
por: Boyle, Marie, et al.
Publicado: (2019)

Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease
por: Zeybel, Müjdat, et al.
Publicado: (2015)

Implementation of a care bundle improves the management of patients with non-alcoholic fatty liver disease
por: Neilson, Laura Jane, et al.
Publicado: (2021)

Accuracy of Routine Clinical Ultrasound for Staging of Liver Fibrosis
por: Choong, Chih-Ching, et al.
Publicado: (2012)

Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results
por: Halfon, Philippe, et al.
Publicado: (2021)

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 3: special circumstances
por: Mansour, Dina, et al.
Publicado: (2023)

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 2: decompensated cirrhosis
por: Mansour, Dina, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: new treatments
por: Hardy, Timothy, et al.
Publicado: (2015)

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 1: compensated cirrhosis
por: Mansour, Dina, et al.
Publicado: (2023)

Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
por: Dongiovanni, Paola, et al.
Publicado: (2013)

Multiplex transcriptional analysis of paraffin-embedded liver needle biopsy from patients with liver fibrosis
por: Staten, Nicholas R, et al.
Publicado: (2012)

FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis
por: Vali, Yasaman, et al.
Publicado: (2021)

Embedding Child Rights Principles and Practises in Mega Sport Event Planning
por: Aina, Oluwaseyi, et al.
Publicado: (2021)

Alignment of Physician-Stated vs Clinically Derived Reference Fibrosis Score in Patients with Non-Alcoholic Steatohepatitis: A Real-World European Survey
por: Anstee, Quentin M, et al.
Publicado: (2023)

Real-time monitoring of liver fibrosis through embedded sensors in a microphysiological system
por: Farooqi, Hafiz Muhammad Umer, et al.
Publicado: (2021)

Embedding and Integrating a Digital Patient Management Platform Into Everyday Primary Care Routines: Qualitative Case Study
por: Frennert, Susanne, et al.
Publicado: (2022)

Improved outcomes following the implementation of a decompensated cirrhosis discharge bundle
por: Smethurst, Katherine, et al.
Publicado: (2021)

Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice
por: Lazarus, Jeffrey V., et al.
Publicado: (2022)

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
por: McPherson, Stuart, et al.
Publicado: (2017)

Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data
por: Paljarvi, Tapio, et al.
Publicado: (2022)

Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis
por: Kozumi, Kazuhiro, et al.
Publicado: (2021)

Liver Fibrosis in Primary Sjögren’s Syndrome
por: Androutsakos, Theodoros, et al.
Publicado: (2022)

Progression of Liver Fibrosis in HIV/HCV Co-Infection: A Comparison between Non-Invasive Assessment Methods and Liver Biopsy
por: Schmid, Patrick, et al.
Publicado: (2015)

Prognostic accuracy of FIB‐4, NAFLD fibrosis score and APRI for NAFLD‐related events: A systematic review
por: Lee, Jenny, et al.
Publicado: (2021)

Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies
por: Jarvis, Helen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ooj9bglupltkm1qv3m7clh0g0v